Association Between SLC2A9 Transporter Gene Variants and Uric Acid Phenotypes in African American and White Families

Overview

Journal Rheumatology (Oxford)

Publisher Oxford University Press

Specialty Rheumatology

Date 2010 Dec 28

PMID 21186168

Citations 15

Authors

Andrew D Rule

Mariza de Andrade

Martha Matsumoto

Tom H Mosley

Sharon Kardia

Stephen T Turner

Affiliations

Soon will be listed here.

Abstract

Objectives: SLC2A9 gene variants associate with serum uric acid in white populations, but little is known about African American populations. Since SLC2A9 is a transporter, gene variants may be expected to associate more closely with the fractional excretion of urate, a measure of renal tubular transport, than with serum uric acid, which is influenced by production and extrarenal clearance.

Methods: Genotypes of single nucleotide polymorphisms (SNPs) distributed across the SLC2A9 gene were obtained in the Genetic Epidemiology Network of Arteriopathy cohorts. The associations of SNPs with serum uric acid, fractional excretion of urate and urine urate-to-creatinine ratio were assessed with adjustments for age, sex, diuretic use, BMI, homocysteine and triglycerides.

Results: We identified SLC2A9 gene variants that were associated with serum uric acid in 1155 African American subjects (53 SNPs) and 1132 white subjects (63 SNPs). The most statistically significant SNPs in African American subjects (rs13113918) and white subjects (rs11723439) were in the latter half of the gene and explained 2.7 and 2.8% of the variation in serum uric acid, respectively. After adjustment for this SNP in African Americans, 0.9% of the variation in serum uric acid was explained by an SNP (rs1568318) in the first half of the gene. Unexpectedly, SLC2A9 gene variants had stronger associations with serum uric acid than with fractional excretion of urate.

Conclusions: These findings support two different loci by which SLC2A9 variants affect uric acid levels in African Americans and suggest SLC2A9 variants affect serum uric acid level via renal and extrarenal clearance.

Citing Articles

A combination of red and processed meat intake and polygenic risk score influences the incidence of hyperuricemia in middle-aged Korean adults.

Lee S, Shin D Nutr Res Pract. 2024; 18(5):721-745.

PMID: 39398885 PMC: 11464275. DOI: 10.4162/nrp.2024.18.5.721.

SLC2A9 rs16890979 reduces uric acid absorption by kidney organoids.

Wu S, Li C, Li Y, Liu J, Rong C, Pei H Front Cell Dev Biol. 2024; 11:1268226.

PMID: 38269090 PMC: 10806012. DOI: 10.3389/fcell.2023.1268226.

A genome-wide association study identifies distinct variants associated with pulmonary function among European and African ancestries from the UK Biobank.

Sinkala M, Elsheikh S, Mbiyavanga M, Cullinan J, Mulder N Commun Biol. 2023; 6(1):49.

PMID: 36641522 PMC: 9840173. DOI: 10.1038/s42003-023-04443-8.

Genome-wide Association Study of 24-Hour Urinary Excretion of Calcium, Magnesium, and Uric Acid.

Ware E, Smith J, Zhao W, Ganesvoort R, Curhan G, Pollak M Mayo Clin Proc Innov Qual Outcomes. 2020; 3(4):448-460.

PMID: 31993563 PMC: 6978610. DOI: 10.1016/j.mayocpiqo.2019.08.007.

SLC2A9 Genotype Is Associated with SLC2A9 Gene Expression and Urinary Uric Acid Concentration.

Ware E, Riehle E, Smith J, Zhao W, Turner S, Kardia S PLoS One. 2015; 10(7):e0128593.

PMID: 26167684 PMC: 4500555. DOI: 10.1371/journal.pone.0128593.

References

Short R, Tuttle K . Clinical evidence for the influence of uric acid on hypertension, cardiovascular disease, and kidney disease: a statistical modeling perspective. Semin Nephrol. 2005; 25(1):25-31. DOI: 10.1016/j.semnephrol.2004.09.005. View

Johnson R, Segal M, Srinivas T, Ejaz A, Mu W, Roncal C . Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?. J Am Soc Nephrol. 2005; 16(7):1909-19. DOI: 10.1681/ASN.2005010063. View

Vitart V, Rudan I, Hayward C, Gray N, Floyd J, Palmer C . SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet. 2008; 40(4):437-42. DOI: 10.1038/ng.106. View

So A, Thorens B . Uric acid transport and disease. J Clin Invest. 2010; 120(6):1791-9. PMC: 2877959. DOI: 10.1172/JCI42344. View

Merriman T, Dalbeth N . The genetic basis of hyperuricaemia and gout. Joint Bone Spine. 2010; 78(1):35-40. DOI: 10.1016/j.jbspin.2010.02.027. View

Melton 3rd L . History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996; 71(3):266-74. DOI: 10.4065/71.3.266. View

Weiner D, Tighiouart H, Elsayed E, Griffith J, Salem D, Levey A . Uric acid and incident kidney disease in the community. J Am Soc Nephrol. 2008; 19(6):1204-11. PMC: 2396939. DOI: 10.1681/ASN.2007101075. View

Doring A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S . SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet. 2008; 40(4):430-6. DOI: 10.1038/ng.107. View

Urano W, Taniguchi A, Anzai N, Inoue E, Sekita C, Endou H . Association between GLUT9 and gout in Japanese men. Ann Rheum Dis. 2010; 69(5):932-3. DOI: 10.1136/ard.2009.111096. View

10.

Dehghan A, Kottgen A, Yang Q, Hwang S, Kao W, Rivadeneira F . Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008; 372(9654):1953-61. PMC: 2803340. DOI: 10.1016/S0140-6736(08)61343-4. View

11.

Kountouras J, Magoula I, TSAPAS G, Liatsis I . The effect of mannitol and secretin on the biliary transport of urate in humans. Hepatology. 1996; 23(2):229-33. DOI: 10.1053/jhep.1996.v23.pm0008591845. View

12.

Stark K, Reinhard W, Neureuther K, Wiedmann S, Sedlacek K, Baessler A . Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study. PLoS One. 2008; 3(4):e1948. PMC: 2275796. DOI: 10.1371/journal.pone.0001948. View

13.

Tu H, Chen C, Tovosia S, Ko A, Lee C, Ou T . Associations of a non-synonymous variant in SLC2A9 with gouty arthritis and uric acid levels in Han Chinese subjects and Solomon Islanders. Ann Rheum Dis. 2009; 69(5):887-90. DOI: 10.1136/ard.2009.113357. View

14.

Phay J, Hussain H, Moley J . Cloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9). Genomics. 2000; 66(2):217-20. DOI: 10.1006/geno.2000.6195. View

15.

Mellen P, Bleyer A, Erlinger T, Evans G, Nieto F, Wagenknecht L . Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. Hypertension. 2006; 48(6):1037-42. DOI: 10.1161/01.HYP.0000249768.26560.66. View

16.

Wallace C, Newhouse S, Braund P, Zhang F, Tobin M, Falchi M . Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet. 2008; 82(1):139-49. PMC: 2253977. DOI: 10.1016/j.ajhg.2007.11.001. View

17.

Dinour D, Gray N, Campbell S, Shu X, Sawyer L, Richardson W . Homozygous SLC2A9 mutations cause severe renal hypouricemia. J Am Soc Nephrol. 2009; 21(1):64-72. PMC: 2799278. DOI: 10.1681/ASN.2009040406. View

18.

Forman J, Choi H, Curhan G . Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol. 2006; 18(1):287-92. DOI: 10.1681/ASN.2006080865. View

19.

Daniels P, Kardia S, Hanis C, Brown C, Hutchinson R, Boerwinkle E . Familial aggregation of hypertension treatment and control in the Genetic Epidemiology Network of Arteriopathy (GENOA) study. Am J Med. 2004; 116(10):676-81. DOI: 10.1016/j.amjmed.2003.12.032. View

20.

Obermayr R, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R . Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol. 2008; 19(12):2407-13. PMC: 2588108. DOI: 10.1681/ASN.2008010080. View